Keratinocyte growth factor for the treatment of the acute respiratory distress syndrome (KARE): a randomised, double-blind, placebo-controlled phase 2 trial
2017 ◽
Vol 5
(6)
◽
pp. 484-491
◽
2001 ◽
Vol 27
(10)
◽
pp. 1578-1583
◽
1999 ◽
Vol 27
(Supplement)
◽
pp. 164A
◽
1997 ◽
Vol 12
(4)
◽
pp. 177-182
◽
2009 ◽
Vol 37
(5)
◽
pp. 1678-1684
◽